CRDL vs. LAC
CRDL (Cardiol Therapeutics Inc Class A) and LAC (Lithium Americas Corp.) are both stocks. CRDL operates in Drug Manufacturers - Specialty & Generic (Healthcare), while LAC operates in Other Industrial Metals & Mining (Basic Materials). Over the past year, CRDL returned -7.97% vs 12.55% for LAC. Their 0.18 correlation means their historical movements had little consistent relationship.
Performance
CRDL vs. LAC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRDL achieves a 33.15% return, which is significantly higher than LAC's -34.17% return.
CRDL
- 1D
- 4.96%
- 1M
- 20.95%
- 6M
- 33.59%
- YTD
- 33.15%
- 1Y
- -7.97%
- 3Y*
- 5.39%
- 5Y*
- -10.81%
- 10Y*
- —
- ALL TIME*
- -13.35%
LAC
- 1D
- -0.69%
- 1M
- -23.67%
- 6M
- -41.07%
- YTD
- -34.17%
- 1Y
- 12.55%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -32.68%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.01M | $1.10M | $670.12K | |
| $21.24M | $30.56M | $47.54M |
CRDL vs. LAC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
CRDL Cardiol Therapeutics Inc Class A | 33.15% | -25.48% | 51.80% | -5.79% |
LAC Lithium Americas Corp. | -34.17% | 46.80% | -53.59% | -27.19% |
Correlation
The correlation between CRDL and LAC is 0.25, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.25 |
Correlation (All Time) Calculated using the full available price history since Oct 2, 2023 | 0.18 |
Fundamentals
CRDL:
$146.40M
LAC:
$640.81M
CRDL:
-CA$0.37
LAC:
-$0.26
CRDL:
9.98
LAC:
0.75
CRDL:
CA$0.00
LAC:
$0.00
CRDL:
-CA$25.95K
LAC:
-$580.22K
CRDL:
-CA$34.00M
LAC:
-$52.10M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRDL vs. LAC — Risk / Return Rank
CRDL
LAC
CRDL vs. LAC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cardiol Therapeutics Inc Class A (CRDL) and Lithium Americas Corp. (LAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRDL | LAC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.31 | ||
| Sortino ratioReturn per unit of downside risk | -1.27 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 1.16 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.38 | 0.16 | -0.54 |
| Martin ratioReturn relative to average drawdown | -0.61 | 0.25 | -0.85 |
Loading charts...
Drawdowns
CRDL vs. LAC - Drawdown Comparison
The maximum CRDL drawdown since its inception was -92.71%, which is greater than LAC's maximum drawdown of -81.83%. Use the drawdown chart below to compare losses from any high point for CRDL and LAC.
Loading charts...
Drawdown Indicators
| CRDL | LAC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.71% | -81.83% | -10.88% |
Max Drawdown (1Y)Largest decline over 1 year | -39.14% | -73.03% | +33.89% |
Max Drawdown (3Y)Largest decline over 3 years | -72.73% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -90.72% | — | — |
Current DrawdownCurrent decline from peak | -79.48% | -75.51% | -3.97% |
Average DrawdownAverage peak-to-trough decline | -69.21% | -63.46% | -5.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.12% | 47.39% | -19.27% |
Volatility
CRDL vs. LAC - Volatility Comparison
Cardiol Therapeutics Inc Class A (CRDL) has a higher volatility of 19.68% compared to Lithium Americas Corp. (LAC) at 16.02%. This indicates that CRDL's price experiences larger fluctuations and is considered to be riskier than LAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRDL | LAC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.68% | 16.02% | +3.66% |
Volatility (6M)Calculated over the trailing 6-month period | 42.48% | 49.65% | -7.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.24% | 131.45% | -65.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.05% | 99.78% | -12.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.49% | 99.78% | -13.29% |
Dividends
CRDL vs. LAC - Dividend Comparison
Neither CRDL nor LAC has paid dividends to shareholders.
Financials
CRDL vs. LAC - Financials Comparison
This section allows you to compare key financial metrics between Cardiol Therapeutics Inc Class A and Lithium Americas Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRDL and LAC have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRDL has higher volatility (19.68%) compared to LAC (16.02%). In terms of maximum drawdown, CRDL dropped -92.71% vs LAC's -81.83%.
LAC currently has the higher Sharpe Ratio (0.09 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRDL and LAC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer